Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950103-17-005304
Filing Date
2017-06-01
Accepted
2017-06-01 16:42:37
Documents
10
Period of Report
2017-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 6-K dp76893_6k.htm 6-K 17599
2 EXHIBIT 99.1 dp76893_ex9901.htm EX-99.1 40916
3 EXHIBIT 99.2 dp76893_ex9902.htm EX-99.2 1799
4 EXHIBIT 99.6 dp76893_ex9906.htm EX-99.6 7882
5 GRAPHIC image_001.jpg GRAPHIC 2002
6 GRAPHIC image_002.jpg GRAPHIC 1632
7 GRAPHIC ex9902_p1a.jpg GRAPHIC 112284
8 GRAPHIC ex9902_p1b.jpg GRAPHIC 281038
9 GRAPHIC ex9902_p2a.jpg GRAPHIC 42516
10 GRAPHIC ex9902_p2b.jpg GRAPHIC 250808
  Complete submission text file 0000950103-17-005304.txt   1020547
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Filer) CIK: 0001651625 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37891 | Film No.: 17885256
SIC: 2834 Pharmaceutical Preparations